NanoBRET® Nano-Glo® Detection Systems
Dedicated Detection Solutions for NanoBRET® Protein Interaction Assays
- Measure protein interactions in live cells with full-length proteins
- Use the standard reagent for single-time-point or <2-hour analysis; use the kinetic reagent for extended live-cell measurements
- Increased signal and lower background compared to conventional BRET assays
Catalog Number:
Choose a product
Size
Catalog Number: N1661
Catalog Number: N1662
Catalog Number: N1663
Catalog Number: N2583
Catalog Number: N2584
Catalog Number: N2585
NanoBRET™ タンパク質相互作用アッセイ用の検出試薬
NanoBRET™ assayはNanoLuc® ルシフェラーゼをエネルギー転移ドナー、HaloTag® NanoBRET™ 618 fluorescent Ligand で標識されたHaloTag® タンパク質をエネルギー転移アクセプターとして利用するBRET（生物発光共鳴エネルギー転移）ベースのアッセイで、生細胞内で2つのタンパク質の相互作用を測定することができます。
NanoBRET™ Nano-Glo® Detection System には、ドナーシグナルを生成するためのNanoLuc® ルシフェラーゼの基質であるNanoBRET™ Nano-Glo® Substrateと 蛍光エネルギーアクセプターのためのHaloTag® NanoBRET™ 618 Ligandが含まれます 。HaloTag® NanoBRET™ 618 Ligand は細胞播種時に直接添加し、NanoBRET™ Nano-Glo® Substrateはドナーとアクセプターの発光/蛍光測定直前にサンプルに添加します。
タンパク質間相互作用のためのNanoBRET™ assayについてはNanoBRET™ Protein Interaction Assayをご覧ください。NanoBRET™ Nano-Glo® Detection System は構築済みあるいはカスタム化 NanoBRET™ PPI Assay にも適合します。
Ｎｏｔｅ: Cat.# N1661 is sufficient for 200 assays in 96-well plates or 500 assays in 384-well plates.
Cat.# N1662 is sufficient for 1,000 assays in 96-well plates or 2,500 assays in 384-well plates.
Cat.# N1663 is sufficient for 10,000 assays in 96-well plates or 25,000 assays in 384-well plates.
NanoBRET™ PPI Assay の測定原理
シンプルなプロトコールで時間も短縮
タンパク質相互作用アッセイデータの例
The NanoBRET® Nano-Glo® Detection System provides live-cell analysis for single-time-point or short (<2 hours) kinetic assays.
Activation of the EGFR/GRB2 interaction by EGF induction.
Inhibition of the BRD4/Histone H3.3 interaction by JQ1.
The NanoBRET® Nano-Glo® Kinetic Detection System provides increased signal stability of the bioluminescent donor, enabling interaction kinetics to be assayed for multiple hours.
BRD4 ubiquitination kinetics following treatment with various PROTAC compounds.
Dissociation kinetics of KRAS 2B G12D/BRAF RBD interaction following treatment with KRAS inhibitor.
Protocols
Specifications
Catalog Number:
選択製品の構成品内容
| Item | Part # | Size | Available Separately |
|---|---|---|---|
HaloTag® NanoBRET® 618 Ligand |
G980A | 1 × 20μl | View Product |
NanoBRET® Nano-Glo® Substrate |
N157A | 1 × 50μl | View Product |
BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researcher may use this product for research use only; no commercial use is allowed. Commercial use means any and all uses of this product by a party in exchange for consideration, including, but not limited to (1) use in further product manufacture; (2) use in provision of services, information or data; and (3) resale of the product, whether or not such product is resold for use in research. Researcher shall have no right to modify or otherwise create variations of the product. No other use or transfer of this product is authorized without the prior express written consent of Promega.
For uses of Nano-Glo®-branded reagents intended for energy transfer (such as bioluminescence resonance energy transfer) to acceptors other than a genetically encoded autofluorescent protein, researchers must:
(i) use NanoBRET®-branded energy acceptors (e.g., BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this product; or
(ii) contact Promega to obtain a license for use of the product for energy transfer assays to energy acceptors not manufactured by Promega.
With respect to any uses outside this label license, including any diagnostic, therapeutic, prophylactic or commercial uses, please contact Promega for supply and licensing information. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.
U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.
選択製品の構成品内容
| Item | Part # | Size | Available Separately |
|---|---|---|---|
HaloTag® NanoBRET® 618 Ligand |
G980A | 5 × 20μl | View Product |
NanoBRET® Nano-Glo® Substrate |
N157A | 5 × 50μl | View Product |
BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researcher may use this product for research use only; no commercial use is allowed. Commercial use means any and all uses of this product by a party in exchange for consideration, including, but not limited to (1) use in further product manufacture; (2) use in provision of services, information or data; and (3) resale of the product, whether or not such product is resold for use in research. Researcher shall have no right to modify or otherwise create variations of the product. No other use or transfer of this product is authorized without the prior express written consent of Promega.
For uses of Nano-Glo®-branded reagents intended for energy transfer (such as bioluminescence resonance energy transfer) to acceptors other than a genetically encoded autofluorescent protein, researchers must:
(i) use NanoBRET®-branded energy acceptors (e.g., BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this product; or
(ii) contact Promega to obtain a license for use of the product for energy transfer assays to energy acceptors not manufactured by Promega.
With respect to any uses outside this label license, including any diagnostic, therapeutic, prophylactic or commercial uses, please contact Promega for supply and licensing information. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.
U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.
選択製品の構成品内容
| Item | Part # | Size | Concentration | Available Separately |
|---|---|---|---|---|
HaloTag® NanoBRET® 618 Ligand |
G980B | 1 × 1ml | 0.1mM | View Product |
NanoBRET® Nano-Glo® Substrate |
N157B | 2 × 1.25ml | View Product |
BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researcher may use this product for research use only; no commercial use is allowed. Commercial use means any and all uses of this product by a party in exchange for consideration, including, but not limited to (1) use in further product manufacture; (2) use in provision of services, information or data; and (3) resale of the product, whether or not such product is resold for use in research. Researcher shall have no right to modify or otherwise create variations of the product. No other use or transfer of this product is authorized without the prior express written consent of Promega.
For uses of Nano-Glo®-branded reagents intended for energy transfer (such as bioluminescence resonance energy transfer) to acceptors other than a genetically encoded autofluorescent protein, researchers must:
(i) use NanoBRET®-branded energy acceptors (e.g., BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this product; or
(ii) contact Promega to obtain a license for use of the product for energy transfer assays to energy acceptors not manufactured by Promega.
With respect to any uses outside this label license, including any diagnostic, therapeutic, prophylactic or commercial uses, please contact Promega for supply and licensing information. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.
U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.
選択製品の構成品内容
| Item | Part # | Size | Available Separately |
|---|---|---|---|
HaloTag® NanoBRET® 618 Ligand |
G980A | 1 × 20μl | View Product |
Nano-Glo® Vivazine® Substrate, 100X |
N258A | 2 × 0.1ml |
BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researcher may use this product for research use only; no commercial use is allowed. Commercial use means any and all uses of this product by a party in exchange for consideration, including, but not limited to (1) use in further product manufacture; (2) use in provision of services, information or data; and (3) resale of the product, whether or not such product is resold for use in research. Researcher shall have no right to modify or otherwise create variations of the product. No other use or transfer of this product is authorized without the prior express written consent of Promega.
For uses of Nano-Glo®-branded reagents intended for energy transfer (such as bioluminescence resonance energy transfer) to acceptors other than a genetically encoded autofluorescent protein, researchers must:
(i) use NanoBRET®-branded energy acceptors (e.g., BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this product; or
(ii) contact Promega to obtain a license for use of the product for energy transfer assays to energy acceptors not manufactured by Promega.
With respect to any uses outside this label license, including any diagnostic, therapeutic, prophylactic or commercial uses, please contact Promega for supply and licensing information. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.
U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.
U.S. Pat. No. 10,836,767; European Pat. No. 3649130 and Japanese Pat. No. 7204728.
選択製品の構成品内容
| Item | Part # | Size | Available Separately |
|---|---|---|---|
HaloTag® NanoBRET® 618 Ligand |
G980A | 5 × 20μl | View Product |
Nano-Glo® Vivazine® Substrate, 100X |
N258B | 1 × 1ml |
BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researcher may use this product for research use only; no commercial use is allowed. Commercial use means any and all uses of this product by a party in exchange for consideration, including, but not limited to (1) use in further product manufacture; (2) use in provision of services, information or data; and (3) resale of the product, whether or not such product is resold for use in research. Researcher shall have no right to modify or otherwise create variations of the product. No other use or transfer of this product is authorized without the prior express written consent of Promega.
For uses of Nano-Glo®-branded reagents intended for energy transfer (such as bioluminescence resonance energy transfer) to acceptors other than a genetically encoded autofluorescent protein, researchers must:
(i) use NanoBRET®-branded energy acceptors (e.g., BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this product; or
(ii) contact Promega to obtain a license for use of the product for energy transfer assays to energy acceptors not manufactured by Promega.
With respect to any uses outside this label license, including any diagnostic, therapeutic, prophylactic or commercial uses, please contact Promega for supply and licensing information. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.
U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.
U.S. Pat. No. 10,836,767; European Pat. No. 3649130 and Japanese Pat. No. 7204728.
選択製品の構成品内容
| Item | Part # | Size | Concentration | Available Separately |
|---|---|---|---|---|
HaloTag® NanoBRET® 618 Ligand |
G980B | 1 × 1ml | 0.1mM | View Product |
Nano-Glo® Vivazine® Substrate, 100X |
N258B | 10 × 1ml |
BY USE OF THIS PRODUCT, RESEARCHER AGREES TO BE BOUND BY THE TERMS OF THIS LIMITED USE LABEL LICENSE. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researcher may use this product for research use only; no commercial use is allowed. Commercial use means any and all uses of this product by a party in exchange for consideration, including, but not limited to (1) use in further product manufacture; (2) use in provision of services, information or data; and (3) resale of the product, whether or not such product is resold for use in research. Researcher shall have no right to modify or otherwise create variations of the product. No other use or transfer of this product is authorized without the prior express written consent of Promega.
For uses of Nano-Glo®-branded reagents intended for energy transfer (such as bioluminescence resonance energy transfer) to acceptors other than a genetically encoded autofluorescent protein, researchers must:
(i) use NanoBRET®-branded energy acceptors (e.g., BRET-optimized HaloTag® ligands) for all determinations of energy transfer activity by this product; or
(ii) contact Promega to obtain a license for use of the product for energy transfer assays to energy acceptors not manufactured by Promega.
With respect to any uses outside this label license, including any diagnostic, therapeutic, prophylactic or commercial uses, please contact Promega for supply and licensing information. PROMEGA MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING FOR MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, WITH REGARD TO THE PRODUCT. The terms of this label license shall be governed under the laws of the State of Wisconsin, USA.
U.S. Pat. No. 8,809,529, European Pat. No. 2635582, Japanese Pat. No. 5889910 and other patents and patents pending.
U.S. Pat. No. 10,836,767; European Pat. No. 3649130 and Japanese Pat. No. 7204728.
Resources
技術記事
- Discovery of an orally bioavailable and selective PKMYT1 inhibitor, RP-6306
- Application of bioluminescence resonance energy transfer assays in primary mouse neuronal cultures
- Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity
Related Products
類似製品
関連製品
FuGENE® HD Transfection Reagent
トランスフェクション困難な細胞株を含む広範な細胞腫に、より優れたパフォーマンス
E2311, E2312
ViaFect™ Transfection Reagent
iPS細胞など様々な細胞株に使える、高効率・低毒性なトランスフェクション試薬
E4981, E4982
ViaScript® LgBiT mRNA Delivery System
内在性タンパク質の発現をリアルタイムで定量化可能
NE1120, NE1130, NE1140
NanoBRET® BiBRET PPI Starter System
Live-cell PPI detection using bright NanoBRET® chemistry and single-vector convenience.
CS1679C169
